We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
27 hedge funds and large institutions have $3.99M invested in Regulus Therapeutics in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
0.12% less ownership
Funds ownership: 2.3% → 2.18% (-0.12%)
8% less capital invested
Capital invested by funds: $4.32M → $3.99M (-$326K)
21% less funds holding
Funds holding: 34 → 27 (-7)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Holders
27
Holders Change
-7
Holders Change %
-20.59%
% of All Funds
0.54%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
2
Increased
8
Reduced
4
Closed
9
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$6K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$1.16M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$71.6K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$48K |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
+$32.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$12.3K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$201K |
| 2 |
VF
Virtu Financial
New York
|
-$57K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$44K |
| 4 |
SG Americas Securities
New York
|
-$24K |
| 5 |
Jane Street
New York
|
-$14K |
